OVARIAN CANCER and US: IMGN853

Blog Archives: Nov 2004 - present

#ovariancancers



Special items: Ovarian Cancer and Us blog best viewed in Firefox

Search This Blog

Showing posts with label IMGN853. Show all posts
Showing posts with label IMGN853. Show all posts

Tuesday, April 17, 2012

financial news: ImmunoGen Says IND For Anticancer Compound IMGN853 Is Now Active



ImmunoGen Says IND For Anticancer Compound IMGN853 Is Now Active


(RTTNews.com) - ImmunoGen, Inc. (IMGN) announced that the Investigational New Drug, or IND, application for its IMGN853 product candidate is now active. IMGN853 is a potential new therapeutic for ovarian cancer, non-small cell lung cancer and other epithelial malignancies which over-express folate receptor 1, or FOLR1.
The company expects Phase I evaluation of IMGN853 to commence in the middle of 2012.....